Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified FLOT in Advanced Gastric Cancer
NCT03606928Phase 2Completed
- Sponsor
- Ruijin Hospital
- Start
- Jul 2018
- Primary completion
- Nov 2019
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin, fluorouracil, folinic acid in gastric cancer (GC), sponsored by Ruijin Hospital. Started Jul 2018; status: completed.
02
Drugs
docetaxeloxaliplatinfluorouracilfolinic acid
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03606928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03606928.